>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

President Obama’s proposal for health care reform unveiled before Feb. 25 health summit

Monday, February 22, 2010

Today, the White House released President Obama’s proposal for health care reform in advance of the bi-partisan health summit to be held this Thursday, Feb. 25 at the Blair House in Washington, D.C.

According to the White House’s website, “The President’s Proposal builds off of the legislation that passed the Senate and improves on it by bridging key differences between the House and the Senate as well as by incorporating Republican provisions that strengthen the proposal.”

ASA opposes H.R. 3590, the Patient Protection and Affordable Care Act, the bill passed by the Senate on December 24, 2009. The bill passed the Senate by a vote of 60-39.

Among new provisions not previously included in either the House or Senate bill, a new Health Insurance Rate Authority would be created to provide Federal assistance and oversight to States in conducting reviews of unreasonable rate increases and other unfair practices of insurance plans.

ASA anticipates significant changes to the current proposal, making the path forward to meaningful reform unclear. ASA is currently reviewing the President’s proposal for health reform and will monitor the discussions as they unfold.

Please visit the links below for more information.

White House link to President Obama’s Proposal

Summary of President Obama’s Proposal

ASA Letter of Opposition to Senate bill

Summary of Senate bill as passed on December 24, 2009

« Back to Washington Alerts